Progress and Prospects on Vaccine Development against SARS-CoV-2.
Identifieur interne : 000362 ( 2020/Analysis ); précédent : 000361; suivant : 000363Progress and Prospects on Vaccine Development against SARS-CoV-2.
Auteurs : Jinyong Zhang [République populaire de Chine] ; Hao Zeng [République populaire de Chine] ; Jiang Gu [République populaire de Chine] ; Haibo Li [République populaire de Chine] ; Lixin Zheng [États-Unis] ; Quanming Zou [République populaire de Chine]Source :
- Vaccines [ 2076-393X ] ; 2020.
Abstract
In December 2019, the outbreak of pneumonia caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to a serious pandemic in China and other countries worldwide. So far, more than 460,000 confirmed cases were diagnosed in nearly 190 countries, causing globally over 20,000 deaths. Currently, the epidemic is still spreading and there is no effective means to prevent the infection. Vaccines are proved to be the most effective and economical means to prevent and control infectious diseases. Several countries, companies, and institutions announced their programs and progress on vaccine development against the virus. While most of the vaccines are under design and preparation, there are some that have entered efficacy evaluation in animals and initial clinical trials. This review mainly focused on the progress and our prospects on field of vaccine development against SARS-CoV-2.
DOI: 10.3390/vaccines8020153
PubMed: 32235387
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000415
- to stream PubMed, to step Curation: 000415
- to stream PubMed, to step Checkpoint: 000295
- to stream Ncbi, to step Merge: 003679
- to stream Ncbi, to step Curation: 003679
- to stream Ncbi, to step Checkpoint: 003679
- to stream Main, to step Merge: 000362
- to stream Main, to step Curation: 000362
- to stream Main, to step Exploration: 000362
- to stream 2020, to step Extraction: 000362
Links to Exploration step
pubmed:32235387Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Progress and Prospects on Vaccine Development against SARS-CoV-2.</title><author><name sortKey="Zhang, Jinyong" sort="Zhang, Jinyong" uniqKey="Zhang J" first="Jinyong" last="Zhang">Jinyong Zhang</name><affiliation wicri:level="1"><nlm:affiliation>National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Third Military Medical University, Chongqing, 400038, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Third Military Medical University, Chongqing, 400038</wicri:regionArea><wicri:noRegion>400038</wicri:noRegion></affiliation></author><author><name sortKey="Zeng, Hao" sort="Zeng, Hao" uniqKey="Zeng H" first="Hao" last="Zeng">Hao Zeng</name><affiliation wicri:level="1"><nlm:affiliation>National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Third Military Medical University, Chongqing, 400038, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Third Military Medical University, Chongqing, 400038</wicri:regionArea><wicri:noRegion>400038</wicri:noRegion></affiliation></author><author><name sortKey="Gu, Jiang" sort="Gu, Jiang" uniqKey="Gu J" first="Jiang" last="Gu">Jiang Gu</name><affiliation wicri:level="1"><nlm:affiliation>National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Third Military Medical University, Chongqing, 400038, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Third Military Medical University, Chongqing, 400038</wicri:regionArea><wicri:noRegion>400038</wicri:noRegion></affiliation></author><author><name sortKey="Li, Haibo" sort="Li, Haibo" uniqKey="Li H" first="Haibo" last="Li">Haibo Li</name><affiliation wicri:level="1"><nlm:affiliation>National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Third Military Medical University, Chongqing, 400038, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Third Military Medical University, Chongqing, 400038</wicri:regionArea><wicri:noRegion>400038</wicri:noRegion></affiliation></author><author><name sortKey="Zheng, Lixin" sort="Zheng, Lixin" uniqKey="Zheng L" first="Lixin" last="Zheng">Lixin Zheng</name><affiliation wicri:level="2"><nlm:affiliation>Laboratory of the Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Laboratory of the Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author><author><name sortKey="Zou, Quanming" sort="Zou, Quanming" uniqKey="Zou Q" first="Quanming" last="Zou">Quanming Zou</name><affiliation wicri:level="1"><nlm:affiliation>National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Third Military Medical University, Chongqing, 400038, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Third Military Medical University, Chongqing, 400038</wicri:regionArea><wicri:noRegion>400038</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32235387</idno><idno type="pmid">32235387</idno><idno type="doi">10.3390/vaccines8020153</idno><idno type="wicri:Area/PubMed/Corpus">000415</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000415</idno><idno type="wicri:Area/PubMed/Curation">000415</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000415</idno><idno type="wicri:Area/PubMed/Checkpoint">000295</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000295</idno><idno type="wicri:Area/Ncbi/Merge">003679</idno><idno type="wicri:Area/Ncbi/Curation">003679</idno><idno type="wicri:Area/Ncbi/Checkpoint">003679</idno><idno type="wicri:doubleKey">2076-393X:2020:Zhang J:progress:and:prospects</idno><idno type="wicri:Area/Main/Merge">000362</idno><idno type="wicri:Area/Main/Curation">000362</idno><idno type="wicri:Area/Main/Exploration">000362</idno><idno type="wicri:Area/2020/Extraction">000362</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Progress and Prospects on Vaccine Development against SARS-CoV-2.</title><author><name sortKey="Zhang, Jinyong" sort="Zhang, Jinyong" uniqKey="Zhang J" first="Jinyong" last="Zhang">Jinyong Zhang</name><affiliation wicri:level="1"><nlm:affiliation>National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Third Military Medical University, Chongqing, 400038, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Third Military Medical University, Chongqing, 400038</wicri:regionArea><wicri:noRegion>400038</wicri:noRegion></affiliation></author><author><name sortKey="Zeng, Hao" sort="Zeng, Hao" uniqKey="Zeng H" first="Hao" last="Zeng">Hao Zeng</name><affiliation wicri:level="1"><nlm:affiliation>National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Third Military Medical University, Chongqing, 400038, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Third Military Medical University, Chongqing, 400038</wicri:regionArea><wicri:noRegion>400038</wicri:noRegion></affiliation></author><author><name sortKey="Gu, Jiang" sort="Gu, Jiang" uniqKey="Gu J" first="Jiang" last="Gu">Jiang Gu</name><affiliation wicri:level="1"><nlm:affiliation>National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Third Military Medical University, Chongqing, 400038, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Third Military Medical University, Chongqing, 400038</wicri:regionArea><wicri:noRegion>400038</wicri:noRegion></affiliation></author><author><name sortKey="Li, Haibo" sort="Li, Haibo" uniqKey="Li H" first="Haibo" last="Li">Haibo Li</name><affiliation wicri:level="1"><nlm:affiliation>National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Third Military Medical University, Chongqing, 400038, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Third Military Medical University, Chongqing, 400038</wicri:regionArea><wicri:noRegion>400038</wicri:noRegion></affiliation></author><author><name sortKey="Zheng, Lixin" sort="Zheng, Lixin" uniqKey="Zheng L" first="Lixin" last="Zheng">Lixin Zheng</name><affiliation wicri:level="2"><nlm:affiliation>Laboratory of the Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Laboratory of the Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author><author><name sortKey="Zou, Quanming" sort="Zou, Quanming" uniqKey="Zou Q" first="Quanming" last="Zou">Quanming Zou</name><affiliation wicri:level="1"><nlm:affiliation>National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Third Military Medical University, Chongqing, 400038, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Third Military Medical University, Chongqing, 400038</wicri:regionArea><wicri:noRegion>400038</wicri:noRegion></affiliation></author></analytic><series><title level="j">Vaccines</title><idno type="ISSN">2076-393X</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In December 2019, the outbreak of pneumonia caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to a serious pandemic in China and other countries worldwide. So far, more than 460,000 confirmed cases were diagnosed in nearly 190 countries, causing globally over 20,000 deaths. Currently, the epidemic is still spreading and there is no effective means to prevent the infection. Vaccines are proved to be the most effective and economical means to prevent and control infectious diseases. Several countries, companies, and institutions announced their programs and progress on vaccine development against the virus. While most of the vaccines are under design and preparation, there are some that have entered efficacy evaluation in animals and initial clinical trials. This review mainly focused on the progress and our prospects on field of vaccine development against SARS-CoV-2.</div></front></TEI><affiliations><list><country><li>République populaire de Chine</li><li>États-Unis</li></country><region><li>Maryland</li></region></list><tree><country name="République populaire de Chine"><noRegion><name sortKey="Zhang, Jinyong" sort="Zhang, Jinyong" uniqKey="Zhang J" first="Jinyong" last="Zhang">Jinyong Zhang</name></noRegion><name sortKey="Gu, Jiang" sort="Gu, Jiang" uniqKey="Gu J" first="Jiang" last="Gu">Jiang Gu</name><name sortKey="Li, Haibo" sort="Li, Haibo" uniqKey="Li H" first="Haibo" last="Li">Haibo Li</name><name sortKey="Zeng, Hao" sort="Zeng, Hao" uniqKey="Zeng H" first="Hao" last="Zeng">Hao Zeng</name><name sortKey="Zou, Quanming" sort="Zou, Quanming" uniqKey="Zou Q" first="Quanming" last="Zou">Quanming Zou</name></country><country name="États-Unis"><region name="Maryland"><name sortKey="Zheng, Lixin" sort="Zheng, Lixin" uniqKey="Zheng L" first="Lixin" last="Zheng">Lixin Zheng</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000362 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd -nk 000362 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= 2020
|étape= Analysis
|type= RBID
|clé= pubmed:32235387
|texte= Progress and Prospects on Vaccine Development against SARS-CoV-2.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/RBID.i -Sk "pubmed:32235387" \
| HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |